Standard or custom package
excellent quality and reliable supplier
*The following content is generated by AI and is for reference only.
Overview
Vemurafenib is a targeted kinase inhibitor developed for oncology therapy. Its molecular formula is C23H17ClN6O with CAS number 913807-42-8.
Application
- Cancer Treatment: Specifically for BRAF V600E mutation-positive metastatic melanoma.
- Pharmaceutical Manufacturing: Used as an active pharmaceutical ingredient (API) in tablet formulations.
- Research & Development: Utilized in clinical trials for studying MAPK pathway inhibition mechanisms.
Precautions
Strictly indicated only for patients with confirmed BRAF V600E mutations. Requires specialized storage conditions away from moisture and light. Handling must follow PPE protocols to prevent dermal exposure.